Clinafloxacin is an investigational fluoroquinolone antibiotic characterized by its chlorinated quinoline structure, which functions by inhibiting bacterial DNA gyrase and topoisomerase IV to treat various… Read more
Clinafloxacin is an investigational fluoroquinolone antibiotic characterized by its chlorinated quinoline structure, which functions by inhibiting bacterial DNA gyrase and topoisomerase IV to treat various Gram-positive and Gram-negative infections. Due to the complexities surrounding its clinical development and safety profile, it remains a subject of ongoing research into novel antimicrobial agents. This category provides access to high-quality reference standards, including the active pharmaceutical ingredient and its hydrochloride salt, alongside essential related compounds such as impurities, metabolites, and stable isotope-labelled materials. These analytical tools are critical for rigorous impurity profiling, bioanalytical method validation, and quality control procedures. By utilizing these precise reference materials, laboratories can ensure the accuracy and reliability of their investigations into the pharmacology and chemical stability of this antibiotic throughout its development and testing phases.